BridgeBio Pharma, Inc. (BBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$64.5
Day's range
$66.37

BridgeBio Pharma Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
JUPITER TOPCO LLC 08/14/2026 14.11 M $1.05 B   100.00% 7.24%
KOHLBERG KRAVIS ROBERTS & CO. L.P. 08/14/2026 13.26 M $987.68 M   0.00% 6.81%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 10.74 M $800.14 M   14.71% 5.52%
BLACKROCK, INC. 08/07/2026 10.29 M $766.19 M   -27.59% 5.28%
VIKING GLOBAL INVESTORS LP 08/14/2026 9.95 M $741.02 M   -15.99% 5.11%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 7.90 M $588.32 M   1.80% 4.06%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 7.66 M $570.27 M   -5.25% 3.93%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 5.31 M $395.41 M   113.73% 2.73%
TWO SIGMA INVESTMENTS, LP 08/14/2026 4.72 M $351.71 M   51.32% 2.42%
AISLING CAPITAL MANAGEMENT LP 08/13/2026 4.59 M $341.83 M   -9.82% 2.36%
STATE STREET CORP 08/07/2026 4.44 M $330.39 M   -10.10% 2.28%
UBS GROUP AG 08/13/2026 3.86 M $287.75 M   0.00% 1.98%
CITADEL ADVISORS LLC 08/14/2026 3.76 M $280.05 M   18.47% 1.93%
INVESCO LTD. 08/14/2026 3.70 M $275.65 M   -19.42% 1.90%
D. E. SHAW & CO., INC. 08/14/2026 3.63 M $270.59 M   42.72% 1.87%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 3.42 M $254.67 M   -30.49% 1.75%
JANE STREET GROUP, LLC 08/14/2026 3.12 M $232.41 M   0.69% 1.60%
JANE STREET GROUP, LLC 08/14/2026 2.93 M $218.54 M   66.94% 1.51%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 2.62 M $195.15 M   9.88% 1.35%
JPMORGAN CHASE & CO 08/12/2026 2.40 M $173.23 M   82.74% 1.23%
ADAGE CAPITAL PARTNERS GP, L.L.C. 08/14/2026 2.25 M $167.73 M   275.96% 1.16%
FRANKLIN RESOURCES INC 08/13/2026 2.16 M $160.89 M   -11.43% 1.11%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 2.06 M $153.70 M   -18.09% 1.06%
FMR LLC 08/13/2026 2.06 M $153.53 M   -12.05% 1.06%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 08/14/2026 1.96 M $145.66 M   -1.08% 1.00%
SC US (TTGP), LTD. 08/14/2026 1.86 M $138.56 M   0.00% 0.96%
GOLDMAN SACHS GROUP INC 08/14/2026 1.81 M $135.16 M   -4.38% 0.93%
UBS GROUP AG 08/13/2026 1.76 M $130.87 M   -13.31% 0.90%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.73 M $128.58 M   -54.59% 0.89%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 1.71 M $127.32 M   -13.50% 0.88%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 1.71 M $127.32 M   100.00% 0.88%
NORGES BANK 08/12/2026 1.69 M $126.15 M   100.00% 0.87%
MORGAN STANLEY 08/13/2026 1.69 M $126.14 M   -9.79% 0.87%
AMERIPRISE FINANCIAL INC 08/14/2026 1.55 M $115.57 M   24.28% 0.80%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 08/14/2026 1.55 M $115.31 M   -55.10% 0.79%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 1.53 M $113.64 M   100.00% 0.78%
ALLIANCEBERNSTEIN L.P. 08/14/2026 1.45 M $107.94 M   -23.86% 0.75%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 1.45 M $107.36 M   4.85% 0.74%
FRONTIER CAPITAL MANAGEMENT CO LLC 08/14/2026 1.37 M $102.27 M   43.33% 0.70%
LAURION CAPITAL MANAGEMENT LP 08/13/2026 1.35 M $100.71 M   7.09% 0.69%
HOOD RIVER CAPITAL MANAGEMENT LLC 08/14/2026 1.35 M $100.36 M   6.52% 0.69%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.24 M $92.01 M   -3.92% 0.63%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.23 M $91.61 M   251.35% 0.63%
SQUAREPOINT OPS LLC 08/14/2026 1.19 M $88.76 M   114.22% 0.61%
BELLEVUE GROUP AG 08/14/2026 1.19 M $88.59 M   4,587.34% 0.61%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 1.16 M $86.06 M   -11.61% 0.59%
GW&K INVESTMENT MANAGEMENT, LLC 08/12/2026 1.13 M $83.80 M   16.88% 0.58%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 1.12 M $83.19 M   -4.95% 0.57%
HRT FINANCIAL LP 08/14/2026 1.09 M $81.14 M   1,415.86% 0.56%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 1.02 M $76.30 M   -23.00% 0.53%

BridgeBio Pharma Inc institutional Ownership - FAQ's

During the previous two years, 617 institutional investors and hedge funds held shares of BridgeBio Pharma Inc. The most heavily invested institutionals were:

Jupiter Topco LLC: 14.11 M

Kohlberg Kravis Roberts & Co. L.P.: 13.26 M

FARALLON CAPITAL MANAGEMENT LLC: 10.74 M

BlackRock, Inc.: 10.29 M

VIKING GLOBAL INVESTORS LP: 9.95 M

VANGUARD CAPITAL MANAGEMENT LLC: 7.9 M

100.20% of BridgeBio Pharma Inc stock is owned by institutional investors.

Institutional investors have bought a total of 247.77 M shares in the last 24 months. This purchase volume represents approximately $16.26 B in transactions.